Key physiological features include: Filaggrin gene mutations , leading to a compromised skin barrier and increased transepidermal water loss Th2-skewed immune response , with elevated IL-4, IL-13, and IgE levels Colonization with Staphylococcus aureus , often contributing to inflammation and secondary infection Heightened mast cell activity , promoting pruritus and dermal reactivity This pathophysiology supports a dual treatment approach: barrier repair and inflammation modulation , often in combination with antimicrobial or immunosuppressive strategies
At our pharmacy, well take time to discuss your medical background and guide you toward the safest option
Update your dosage chart accordingly and label the vial with the correct concentration
\Low Immunogenicity: Did not lead to antibody formation in studies up to 24 weeks (Human Study)
NHS-approved alternatives including semaglutide (Wegovy) and tirzepatide (Mounjaro) offer evidence-based, regulated options for weight management